- Home
- GLDD vs XERS Comparison
GLDD vs XERS Comparison
Compare GLDD & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLDD | XERS |
|---|---|---|
| Founded | 1890 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GLDD | XERS |
|---|---|---|
| Price | $16.89 | $6.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $20.00 | $10.43 |
| AVG Volume (30 Days) | ★ 1.8M | 1.4M |
| Earning Date | 01-01-0001 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 300.00 | 17.78 |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $702,503,000.00 | $49,590,000.00 |
| Revenue This Year | $13.16 | $44.77 |
| Revenue Next Year | $5.49 | $27.72 |
| P/E Ratio | $18.77 | ★ N/A |
| Revenue Growth | N/A | ★ 142.67 |
| 52 Week Low | $7.51 | $3.58 |
| 52 Week High | $16.99 | $10.08 |
Technical Indicators
Market Signals| Indicator | GLDD | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 70.36 | 36.92 |
| Support Level | $16.85 | $6.26 |
| Resistance Level | $16.92 | $7.07 |
| Average True Range (ATR) | 0.37 | 0.32 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 95.82 | 25.94 |
Price Performance
Historical ComparisonAbout GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).